Angiosarcomas are rare malignant tumors of the endothelium, arising commonly from the
head and neck region (AS-HN) and recently associated with ultraviolet (UV) exposure and …

Angiosarcomas are rare, clinically aggressive tumors with limited treatment options and a
dismal prognosis. We analyzed angiosarcomas from 68 patients, integrating information …

Simple Summary Angiosarcomas (AS) are rare, highly aggressive sarcomas with limited
therapeutic options. Genomic sequencing techniques have identified recurrent genetic …

Cutaneous angiosarcoma (CAS) is a highly malignant tumor with few effective treatments.
Although the indication for immune checkpoint inhibitors such as anti-PD-1 antibodies is …

Despite rare cancers accounting for 25% of adult tumors, they are difficult to study due to the
low disease incidence and geographically dispersed patient populations, which has …

Angiosarcomas are a rare subtype of soft-tissue sarcomas which exhibit aggressive clinical
phenotypes with limited treatment options and poor outcomes. In this study, we investigated …

Understanding the tumor microenvironment is important to efficiently identify appropriate
patients for immunotherapies in a variety of cancers. Here, we presented the tumor …

The tumor microenvironment (TME) plays an important role in the growth and invasion of
glioma. This study aimed to analyze the composition of the immune microenvironment in …

Head and neck squamous cell carcinomas (HNSCCs) are the seventh most common cancer
and represent a global health burden. Immune checkpoint inhibitors (ICIs) have shown …

Simple Summary Angiosarcomas (AS) are rare and aggressive soft tissue sarcomas that can
be subdivided in de novo primary AS and secondary AS. They have a very poor prognosis …